PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 8, 2026Frontiers in Cardiovascular Medicine0 citationsOpen Access

Novel compound heterozygous mutations in KLHL24-induced recessive inherited hypertrophic cardiomyopathy: a case report

WZWenjing ZhouXWX WangJYJiyun Yang

Key Result

Novel compound heterozygous mutations in the KLHL24 gene (c.532del and c.1514A>G) caused severe, early-onset recessive hypertrophic cardiomyopathy in two siblings.

Key Points

  • To report novel mutations in the KLHL24 gene associated with hypertrophic cardiomyopathy in two siblings.
  • Case report detailing clinical evaluations and genetic testing of two siblings
  • Genetic analysis identified compound heterozygous mutations in KLHL24
  • Family screening assessed inheritance pattern and carrier status.
  • Both siblings carried compound heterozygous mutations in KLHL24, with the proband showing progressive symptoms
  • The younger brother exhibited severe biventricular hypertrophy and elevated cardiac biomarkers
  • Bioinformatics analysis predicted pathogenicity, contributing to understanding genetic HCM.

Study Design

Type

Case Report (n=4)

Multicenter

No

Structured PICO

P
Population
Two male siblings (ages 30 and 20) from a non-consanguineous family presenting with hypertrophic cardiomyopathy (HCM).
I
Intervention
Genetic testing (whole-exome sequencing) and clinical evaluation
O
Outcome
Identification of the genetic etiology and clinical phenotype of the hypertrophic cardiomyopathy

This case expands the genetic spectrum of hypertrophic cardiomyopathy by identifying novel compound heterozygous mutations in KLHL24 that cause a severe, early-onset recessive phenotype.

Limitations

  • No functional experiments were performed to validate the functional impact of the identified mutations
  • Follow-up duration was relatively short for the younger brother (only 2 years), limiting the ability to observe long-term outcomes
  • This study included only a single family with a small sample size, so the generalizability of the findings requires caution
  • No functional experiments were performed to validate the functional impact of the identified mutations.
  • Follow-up duration was relatively short for the younger brother (only 2 years).
  • Included only a single family with a small sample size, limiting generalizability.

Abstract

Hypertrophic cardiomyopathy (HCM) is a common hereditary cardiovascular disease, but the genetic etiology of nearly 50% of cases remains unclear. This case report describes two siblings in a non-consanguineous family who presented with HCM caused by novel compound heterozygous mutations in the KLHL24 gene. The proband, a 30-year-old male, initially presented with recurrent syncope at the age of 20, leading to the implantation of a permanent pacemaker. Serial clinical evaluations showed progressive left ventricular hypertrophy, diastolic dysfunction, and a gradual decline in left ventricular ejection fraction. His 20-year-old younger brother, identified through family screening, had no obvious clinical symptoms but exhibited severe biventricular hypertrophy, significantly elevated levels of B-type natriuretic peptide and high-sensitivity troponin T, indicating subclinical myocardial injury and heart failure. Genetic testing confirmed that both siblings carried two heterozygous mutations in KLHL24 : a frameshift mutation (c.532del:p.His178Ilefs*66) in the BACK domain and a missense mutation (c.1514AG:p.Tyr505Cys) in the KELCH domain. Family verification revealed a recessive inheritance pattern, with each parent carrying one of the mutations. Bioinformatics analysis predicted the pathogenicity of these mutations, which have not been previously reported. This case expands the genetic spectrum of HCM and highlights the importance of genetic testing and family screening for KLHL24 -related cardiomyopathies. Regular cardiac monitoring is crucial for carriers of such mutations to enable early intervention and improve outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhou et al. (2026) conducted a case report in Hypertrophic cardiomyopathy (n=4). Whole-exome sequencing was evaluated. Novel compound heterozygous mutations in the KLHL24 gene (c.532del and c.1514A>G) caused severe, early-onset recessive hypertrophic cardiomyopathy in two siblings.

synapsesocial.com/papers/69fd7cd4bfa21ec5bbf05b61https://doi.org/10.3389/fcvm.2026.1771424
Ask AI
Helpful
Bookmark
Share
View Full Paper